CME Group Inc.CMENASDAQ

|||

Overview News Fundamentals Key Metrics TTM Financials Earnings Growth Rating Analysts Institutional Peers Historical

Analyst Sentiment

Analysts are neutral — opinion is divided on direction.

Consensus Rating

Hold

17 analysts·Moderate coverage

53%

Rating Distribution

Strong Buy

00%

Buy

953%

Hold

424%

Sell

424%

Strong Sell

00%

Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.

Price Target Expectations

Analysts see modest upside — consensus target 13% higher.

Bear Case

$280.00

+4%

Consensus

$302.20

+13%

Bull Case

$320.00

+19%

Price Range17 analysts

Low

Consensus

High

$280.00

$320.00

Current Target

Current Price

$268.45

Upside to Target

$33.75

Price targets are 12-month forecasts. Actual results depend on earnings, market conditions, and sector trends.

Earnings & Revenue Estimates

2026E$11.64(9 analysts)

P/E26x

Current: 25.7x

Actual

Estimate

Range (Low–High)

Stock Alarm Pro

Forward Growth Estimates (YoY)

FY2027

Rev+5.51%

EPS+6.55%

FY2028

Rev+6.68%

EPS+11.79%

FY2029

Rev+4.39%

EPS+7.63%

Earnings Surprises

Beat rate:92%(11/12 quarters)

Avg surprise:+2.0%

Beat

Miss

Inline

Estimate

Based on reported EPS vs consensus estimate.

Recent Analyst Actions

Dec 22, 2025Morgan Stanley

CME Group price target raised to $320 from $314 at Morgan Stanley

Target:$320.00

+18.9%from $269.09

Dec 12, 2025Barclays

CME Group price target raised to $304 from $280 at Barclays

Target:$304.00

+11.6%from $272.42

Oct 23, 2025Morgan Stanley

CME Group price target raised to $314 from $312 at Morgan Stanley

Target:$314.00

+16.5%from $269.50

Oct 23, 2025UBS

CME Group price target lowered to $280 from $285 at UBS

Target:$280.00

+4.6%from $267.81

Oct 23, 2025Deutsche Bank

CME Group upgraded to Buy from Hold at Deutsche Bank

Target:$300.00

+11.3%from $269.59

Oct 13, 2025Raymond James

CME Group price target lowered to $307 from $309 at Raymond James

Target:$307.00

+13.1%from $271.45

Oct 8, 2025Barclays

CME Group price target lowered to $280 from $298 at Barclays

Target:$280.00

+6.2%from $263.60

Oct 1, 2025Morgan Stanley

CME Group price target raised to $312 from $303 at Morgan Stanley

Target:$312.00

+18.0%from $264.46

Sep 8, 2025UBS

CME Group price target lowered to $285 from $305 at UBS

Target:$285.00

+8.9%from $261.78

Jul 24, 2025Barclays

CME Group price target lowered to $298 from $299 at Barclays

Target:$298.00

+7.5%from $277.18

Mar 10, 2025Raymond James

CME Group upgraded to Outperform from Market Perform at Raymond James

Target:$287.00

+12.7%from $254.57

Oct 24, 2024Oppenheimer

CME Group (CME) PT Raised to $258 at Oppenheimer

Target:$258.00

+13.4%from $227.43

Oct 24, 2024Barclays

CME Group price target raised to $231 from $219 at Barclays

Target:$231.00

+1.7%from $227.14

Oct 3, 2024Citigroup

CME Group price target raised to $250 from $240 at Citi

Target:$250.00

+11.8%from $223.57

Sep 26, 2024RBC Capital

CME Group initiated with a Sector Perform at RBC Capital

Target:$235.00

+7.6%from $218.47

Sep 3, 2024Bank of America Securities

CME Group downgraded to Underperform from Neutral at BofA

Target:$177.00

-18.0%from $215.74

Jul 25, 2024Deutsche Bank

CME Group price target lowered to $193 from $195 at Deutsche Bank

Target:$193.00

-3.0%from $198.92

Jul 25, 2024Piper Sandler

CME Group (CME) PT Lowered to $225 at Piper Sandler

Target:$225.00

+12.8%from $199.38

Jul 25, 2024Barclays

CME Group price target raised to $209 from $208 at Barclays

Target:$209.00

+6.0%from $197.25

Jun 5, 2024UBS

UBS Reiterates Buy Rating on CME Group (CME)

Target:$250.00

+22.7%from $203.78

Apr 25, 2024Rosenblatt Securities

CME Group (CME) PT Raised to $187 at Rosenblatt

Target:$187.00

-12.0%from $212.59

Apr 25, 2024Barclays

CME Group price target raised to $228 from $226 at Barclays

Target:$228.00

+7.2%from $212.59

Apr 5, 2024Deutsche Bank

Deutsche Bank Downgrades CME Group (CME) to Hold

Target:$210.00

-1.0%from $212.21

Feb 7, 2023Credit Suisse

Credit Suisse Maintains Outperform on CME Group, Raises Price Target to $198

Target:$198.00

+13.3%from $174.76

Jan 11, 2023Morgan Stanley

Morgan Stanley Maintains Equal-Weight on CME Group, Lowers Price Target to $196

Target:$196.00

+10.8%from $176.93

Explore More

S&P 500 Screener

Filter and sort all 500 stocks

Market Movers

Today's biggest gainers and losers

Market Heatmap

Visual sector performance